Anti-SARS-CoV-2 Neutralizing Antibody (V3S-0623-XY12) (CAT#: V3S-0623-XY12)

Send Inquiry
  • fig1

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target

Summary

Description The anti-SARS-CoV-2 antibody is a human IgG, clone S2P6. S2P6 exhibits the overall greatest cross-reactivity and neutralization breadth. S2P6 is a broadly neutralizing betacoronavirus mAb with activity against SARS-CoV-2 and SARS-CoV-related viruses as well as members of the merbecovirus and embecovirus subgenera.
Clonality Monoclonal
Host Species Human
Target Species SARS-CoV-2
Cross Reactivity SARS-CoV-related viruses, the merbecovirus and embecovirus subgenera
Function Broadly neutralizing betacoronavirus including SARS-CoV-2, SARS-CoV-related viruses, the merbecovirus and embecovirus subgenera.
Isotype IgG1

Property

Expression Species HEK293F or CHO cell line
Conjugation Unconjugated
Purity >95%
Endotoxin <1 EU/mg
Form Liquid
Purification Protein A purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4°C within one or two weeks. Store at -20°C for long term. Avoid repeated freeze/thaw cycles. Refer to the COA file for specifics.

Applications

Application ELISA, Neut

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Western Blot Protocol

Target

Target SARS-CoV-2
Alternative Name Severe acute respiratory syndrome coronavirus 2
Research Area Coronavirus Disease 2019
Related Disease Coronavirus Disease 2019
For research use only, not directly for clinical use.
banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
Online Inquiry